579 related articles for article (PubMed ID: 30359120)
1. Primary Aldosteronism: Practical Approach to Diagnosis and Management.
Byrd JB; Turcu AF; Auchus RJ
Circulation; 2018 Aug; 138(8):823-835. PubMed ID: 30359120
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and diagnosis of primary aldosteronism.
Rossi GP
Curr Hypertens Rep; 2010 Oct; 12(5):342-8. PubMed ID: 20665130
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of primary aldosteronism.
Vilela LAP; Almeida MQ
Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism: diagnostic and therapeutic considerations.
Nishizaka MK; Calhoun DA
Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
[TBL] [Abstract][Full Text] [Related]
6. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
Hundemer GL
Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
[TBL] [Abstract][Full Text] [Related]
7. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
9. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
Ohno Y; Sone M; Inagaki N; Kawashima A; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Ichijo T; Katabami T; Wada N; Sakamoto R; Ogawa Y; Yoshimoto T; Yamada T; Kawashima J; Matsuda Y; Kobayashi H; Kamemura K; Yamamoto K; Otsuki M; Okamura S; Izawa S; Okamoto R; Tamura K; Tanabe A; Naruse M;
Hypertension; 2020 Jun; 75(6):1475-1482. PubMed ID: 32248705
[TBL] [Abstract][Full Text] [Related]
10. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
[TBL] [Abstract][Full Text] [Related]
11. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
Morimoto S; Ichihara A
Hypertens Res; 2020 Aug; 43(8):744-753. PubMed ID: 32424201
[TBL] [Abstract][Full Text] [Related]
12. Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy?
Auchus RJ; Drazner MH
Hypertension; 2007 Nov; 50(5):837-9. PubMed ID: 17909118
[No Abstract] [Full Text] [Related]
13. Personalized Treatment of Patients With Primary Aldosteronism.
Obeid H; Chen Cardenas SM; Khairi S; Turcu AF
Endocr Pract; 2023 Jun; 29(6):484-490. PubMed ID: 36273684
[TBL] [Abstract][Full Text] [Related]
14. Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term.
Rossi GP; Maiolino G; Flego A; Belfiore A; Bernini G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Muiesan ML; Mannelli M; Negro A; Palumbo G; Parenti G; Rossi E; Mantero F;
Hypertension; 2018 Apr; 71(4):585-591. PubMed ID: 29483224
[TBL] [Abstract][Full Text] [Related]
15. Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade.
Pintus G; Seccia TM; Amar L; Azizi M; Riester A; Reincke M; Widimský J; Naruse M; Kocjan T; Negro A; Kline G; Tanabe A; Satoh F; Rump LC; Vonend O; Fuller PJ; Yang J; Chee NYN; Magill SB; Shafigullina Z; Quinkler M; Oliveras A; Lee BC; Chang CC; Wu VC; Krátká Z; Battistel M; Bagordo D; Caroccia B; Ceolotto G; Rossitto G; Rossi GP
Hypertension; 2024 Jun; 81(6):1391-1399. PubMed ID: 38525605
[TBL] [Abstract][Full Text] [Related]
16. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
[TBL] [Abstract][Full Text] [Related]
17. Atrial Fibrillation in Primary Aldosteronism.
Pan CT; Tsai CH; Chen ZW; Chang YY; Wu VC; Hung CS; Lin YH;
Horm Metab Res; 2020 Jun; 52(6):357-365. PubMed ID: 32289838
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of primary aldosteronism: an updated review.
Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
[TBL] [Abstract][Full Text] [Related]
19. Update in primary aldosteronism.
Stowasser M
J Clin Endocrinol Metab; 2009 Oct; 94(10):3623-30. PubMed ID: 19737921
[TBL] [Abstract][Full Text] [Related]
20. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]